Skip to main content
. 2008 Aug 14;14(30):4753–4762. doi: 10.3748/wjg.14.4753

Table 3.

Baseline demographic and disease characteristics in the intention-to-treat population

Characteristics of patients Control Trial P
Sex
Male (%) 104 (54) 169 (53) 0.934
Female (%) 88 (46) 147 (47) 0.927
Age-yr median(IQR 25th & 5th) 35 (23.75-45) 35 (27-45) 0.229
Weight (kg, mean ± SD) 37.61 ± 5.94 38.32 ± 6.08 0.199
Ethnicity (%)1
Tribals 171(89) 287(91) 0.883
Others 21(11) 29(9) 0.559
Habits (%)
Smoking 58 (30.2) 103 (32.6) 0.685
Alcohol 23 (12) 33 (10.4) 0.633
Both 26 (13.5) 53 (16.7) 0.403
Socio-Economic status (%)
Upper-Middle 20 (10.4) 40 (12.6) 0.499
Middle 30 (15.6) 52 (16.4) 0.833
Lower 142 (74) 224 (71) 0.763
Pulmonary (%)2
Open cases (sputum +ve) 67 (35) 137 (43.4) 0.214
Parenchymal 152 (79.2) 258 (81.6) 0.822
Cavitary 18 (9.4) 66 (21) 0.003
Effusion 9 (4.6) 20 (6.3) 0.464
Fibrosis 27 (14) 68 (21.5) 0.081
Extra pulmonary (%)2
Cervical lymph node 18 (9.4) 31 (9.8) 0.883
Abdominal 4 (2.1) 6 (2) 0.886
Laryngeal 7 (3.6) 11 (3.5) 0.925
Central nervous system 6 (3.1) 6 (2) 0.389
Bones/Joints 10 (5.2) 19 (6) 0.72
Skin 0 3 (1) 0.598
Genito-Urinary 2 (1.04) 1 (0.3) 0.304
Type of case (%)
New 140 (73) 195 (61.7) 0.245
Relapse 43 (22.4) 97 (30.7) 0.122
Chronic 9 (4.7) 24 (7.6) 0.225
Hematology
Hb (%) 8.84 ± 1.93 8.95 ± 1.95 0.808
Total leucocyte count/mm3 10 179 ± 4 680 9575 ± 4075 0.478
ESR 66.79 ± 30.64 70.49 ± 27.91 0.517
Liver Function (mean, 95%CI)
Serum bilirubin 1.07 (0.7-1.3) 1.09 (0.8-1.4) 0.952
AST 34.35 (17-63)  32.4 (11-61) 0.658
ALT 27.45 (9-57) 31.15 (6-52) 0.655
ALP 100 (50-260) 107 (50-260) 0.092

Unless stated otherwise, P values were calculated with the use of a two sided t-test with Welch’s modification (when unequal variance) for continuous data and a χ2 test for categorical data.

1

Ethnic group was assessed by investigation on screening. Tribal consists of Chaudhari, Gamit, Vasava, Bhil, Valvi, Nayka and Halpati.

2

Patients may belong to more than one category. ALP: Alkaline phosphatase.